Gastric pentadecapeptide. Pre-clinical evidence in tissue repair; no completed human RCTs for injectable use.

43-amino acid peptide involved in actin sequestration. Animal models suggest wound-healing effects; human evidence limited to case series.

Copper-binding tripeptide with topical applications in wound healing. Some controlled human data for dermal use.

GLP-1 receptor agonist. Extensive Phase III data for glycemic control and weight management. FDA-approved.

Modified GHRH analog. Published human pharmacokinetic data; efficacy evidence limited to single-dose studies.

Melanocortin receptor agonist. FDA-approved for HSDD. Phase III trial data available.